Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5Y4TL | — |
patient received only the diluent; patient received only the diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received Herpes zoster (Shingrix) (batch number 5Y4TL, expiry date 31-JAN-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient received only the diluent ) and inappropriate dose of vaccine administered (Verbatim: patient received only the diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 06-FEB-2025 A medical assistant called to report that a patient received only the diluent portion of Shingrix. The Healthcare professional asked for recommendations on this situation and if she could get an additional diluent vial. The patient received only diluent of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.